Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Zhongze Therapeutics
company
About
Clinical-stage Biotech
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology
- Founded date
- Jul 23, 2021
- Operating Status
- Active
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Zhongze Therapeutics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Apr 21, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2022 | Seed | — | 1 |
CQY Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Zhongze Therapeutics is funded by 1 investors.
CQY Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CQY Capital
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
